News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
620,320 Results
Type
Article (30923)
Company Profile (174)
Press Release (589440)
Multimedia
Podcasts (132)
Webinars (16)
Section
Business (199678)
Career Advice (987)
Deals (31153)
Drug Delivery (127)
Drug Development (84223)
Employer Resources (73)
FDA (14412)
Job Trends (11593)
News (306649)
Policy (26393)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (690)
Accelerated approval (34)
ADA (27)
Adcomms (23)
Allergies (115)
Alliances (36904)
ALS (127)
Alzheimer's disease (1209)
Antibody-drug conjugate (ADC) (364)
Approvals (11472)
Artificial intelligence (483)
ASCO (205)
Autoimmune disease (254)
Automation (35)
Bankruptcy (303)
Best Places to Work (7453)
BIO (57)
Biologics (1)
BIOSECURE Act (10)
Biosimilars (172)
BioSpace Insights (71)
Biotechnology (98)
Bladder cancer (161)
Brain cancer (39)
Breast cancer (576)
Cancer (4373)
Cardiovascular disease (350)
Career advice (708)
Career pathing (29)
CAR-T (218)
CDC (16)
Celiac Disease (2)
Cell therapy (596)
Cervical cancer (39)
Clinical research (53261)
Collaboration (1596)
Commercialization (5)
Company closure (2)
Compensation (1495)
Complete response letters (66)
COVID-19 (1100)
CRISPR (71)
C-suite (945)
Cystic fibrosis (90)
Data (6158)
Decentralized trials (1)
Denatured (18)
Depression (134)
Dermatology (79)
Diabetes (446)
Diagnostics (4554)
Digital health (45)
Diversity (8)
Diversity, equity & inclusion (14)
Drug discovery (246)
Drug pricing (173)
Drug shortages (26)
Duchenne muscular dystrophy (213)
Earnings (76993)
Editorial (51)
Employer branding (7)
Employer resources (63)
Events (93162)
Executive appointments (831)
FDA (13891)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (1177)
Gene editing (156)
Generative AI (45)
Gene therapy (436)
GLP-1 (718)
Government (1707)
Grass and pollen (3)
Guidances (308)
Healthcare (10384)
Hematology (108)
HIV (69)
Huntington's disease (36)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (82)
Immunology and inflammation (250)
Immuno-oncology (88)
Indications (168)
Infectious disease (1358)
Inflammatory bowel disease (153)
Inflation Reduction Act (8)
Influenza (93)
Intellectual property (267)
Interviews (123)
IPO (13350)
IRA (42)
Job creations (2549)
Job search strategy (615)
JPM (42)
Kidney cancer (18)
Labor market (80)
Layoffs (289)
Leadership (31)
Legal (5904)
Licensing (10)
Liver cancer (60)
Longevity (19)
Lung cancer (613)
Lymphoma (318)
Machine learning (36)
Management (26)
Manufacturing (845)
Marketing (10)
MASH (160)
Medical device (8977)
Medtech (9125)
Mergers & acquisitions (16448)
Metabolic disorders (1217)
mRNA (113)
Multiple sclerosis (132)
NASH (12)
Neurodegenerative disease (315)
Neuropsychiatric disorders (80)
Neuroscience (2344)
Neurotech (1)
NextGen: Class of 2026 (3619)
Non-profit (1008)
Now hiring (51)
Obesity (598)
Opinion (189)
Ovarian cancer (172)
Pain (217)
Pancreatic cancer (227)
Parkinson's disease (250)
Partnered (22)
Patents (554)
Patient recruitment (559)
Peanut (36)
People (45524)
Pharmaceutical (39)
Pharmacy benefit managers (28)
Phase 1 (16910)
Phase 2 (23828)
Phase 3 (16735)
Pipeline (8117)
Policy (214)
Postmarket research (1701)
Preclinical (7025)
Press Release (35)
Prostate cancer (219)
Psychedelics (34)
Radiopharmaceuticals (244)
Rare diseases (800)
Real estate (3655)
Recruiting (30)
Regulatory (17145)
Reports (34)
Research institute (793)
Resumes & cover letters (142)
Rett syndrome (41)
RNA editing (15)
RSV (75)
Schizophrenia (158)
Series A (203)
Series B (155)
Service/supplier (7)
Sickle cell disease (79)
Special edition (21)
Spinal muscular atrophy (108)
Sponsored (16)
Startups (2494)
Stomach cancer (12)
Supply chain (95)
Tariffs (93)
The Weekly (72)
Vaccines (505)
Venture capital (99)
Weight loss (394)
Women's health (95)
Worklife (10)
Date
Today (79)
Last 7 days (492)
Last 30 days (2301)
Last 365 days (22000)
2026 (17601)
2025 (27548)
2024 (31553)
2023 (29174)
2022 (44895)
2021 (47424)
2020 (43343)
2019 (26519)
2018 (24436)
2017 (27010)
2016 (25471)
2015 (26623)
2014 (26528)
2013 (22208)
2012 (24163)
2011 (24510)
2010 (23892)
Location
Africa (397)
Alabama (76)
Alaska (2)
Arizona (317)
Arkansas (12)
Asia (23944)
Australia (2911)
California (12354)
Canada (3322)
China (816)
Colorado (512)
Connecticut (450)
Delaware (246)
Europe (41272)
Florida (1886)
Georgia (383)
Hawaii (3)
Idaho (47)
Illinois (759)
India (84)
Indiana (371)
Iowa (17)
Japan (507)
Kansas (104)
Kentucky (31)
Louisiana (29)
Maine (31)
Maryland (1299)
Massachusetts (8251)
Michigan (316)
Minnesota (571)
Mississippi (5)
Missouri (83)
Montana (21)
Nebraska (14)
Nevada (117)
New Hampshire (62)
New Jersey (2882)
New Mexico (25)
New York (2981)
North Carolina (1374)
North Dakota (4)
Northern California (6176)
Ohio (325)
Oklahoma (16)
Oregon (20)
Pennsylvania (2331)
Puerto Rico (28)
Rhode Island (33)
South America (586)
South Carolina (76)
South Dakota (1)
Southern California (5108)
Tennessee (137)
Texas (1961)
United States (40717)
Utah (373)
Vermont (1)
Virginia (172)
Washington D.C. (51)
Washington State (963)
West Virginia (2)
Wisconsin (80)
Wyoming (2)
620,320 Results for "tris pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tris Pharma Launches Adneuris Therapeutics to Advance a New Era in Pain Medicine
July 9, 2026
·
5 min read
Press Releases
Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central
August 12, 2026
·
9 min read
Press Releases
Tris Pharma Announces Presentation on The Complexity and Management of ADHD at Psych Congress Elevate 2026
June 2, 2026
·
2 min read
Press Releases
Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer
May 5, 2026
·
3 min read
Press Releases
Tris Pharma Introduces a New 60 mL Bottle Size for DYANAVEL® XR (amphetamine) Extended-Release Oral Suspension CII
June 9, 2026
·
7 min read
Press Releases
Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology
University of Calgary research demonstrates more than 200-fold improvement in antibacterial performance while Biosenta advances commercialization
July 21, 2026
·
5 min read
Press Releases
Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia
June 10, 2026
·
4 min read
Press Releases
Secretary of State Randeep Sarai Visits University of Calgary to Learn About Biosenta’s Tri-Filler(TM) Technology
August 14, 2026
·
4 min read
Earnings
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
The additional cuts, which will primarily occur between 2027 and 2029, will cost some $6 billion as the pharma tries to ride out a post-COVID headache while facing stiff patent headwinds for major products like the blood thinner Eliquis.
August 4, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026
June 11, 2026
·
3 min read
1 of 62,032
Next
